Ardelyx, Inc. (ARDX) vs Rigel Pharmaceuticals, Inc. (RIGL)
Ardelyx, Inc. and Rigel Pharmaceuticals, Inc. are both Biotechnology companies. Ardelyx, Inc. and Rigel Pharmaceuticals, Inc. are of similar size ($894.6M and $859.7M). Ardelyx, Inc. has negative trailing earnings, so its P/E is not meaningful; Rigel Pharmaceuticals, Inc. trades at 2.7×. Ardelyx, Inc. grew revenue faster over the last twelve months: 16.8% against 3.31%. Rigel Pharmaceuticals, Inc. has the higher net margin (116.3% vs −12.4%) and the higher return on invested capital (16.5% vs −18.6%). Across the 18 metrics below, Rigel Pharmaceuticals, Inc. leads on 12 and Ardelyx, Inc. on 6.
Valuation
Profitability
| Metric | ARDX | RIGL | Biotechnology median |
|---|---|---|---|
| Gross margin | 94.37% | 91.39% | 65.16% |
| Operating margin | (7.86%) | 31.45% | 0.00% |
| Net margin | (12.35%) | 116.30% | 0.00% |
| Free cash flow margin | (3.97%) | 3.19% | 0.00% |
| Return on equity | (38.61%) | 126.90% | (57.72%) |
| Return on assets | (10.68%) | 88.46% | (49.22%) |
| Return on invested capital | (18.62%) | 16.48% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack